PHQ-9 scores can be used to plan and monitor treatment. To score the instrument, tally the numbers of all the checked responses under each heading (not at all=0, several days=1, more than half the days=2, and nearly every day=3). Add the numbers together to total the score on the bottom of the questionnaire. Interpret the score by using the guide listed below.
Guide for Interpreting PHQ-9 Scores | |||||||||
---|---|---|---|---|---|---|---|---|---|
Score | Depression Severity | Action | |||||||
0 - 4 | None-minima | Patient may not need depression treatment. | |||||||
5 - 9 | Mild | Use clinical judgment about treatment, based on patient’s duration of symptoms and functional impairment. | |||||||
10 - 14 | Moderate | Use clinical judgment about treatment, based on patient’s duration of symptoms and functional impairment. | |||||||
15 - 19 | Moderately severe | Treat using antidepressants, psychotherapy or a combination of treatment. | |||||||
20 - 27 | Severe | Treat using antidepressants with or without psychotherapy. |
The instrument also includes a functional health assessment. This asks the patient how emotional difficulties or problems impact work, life at home, or relationships with other people. Patient response of‘very difficult’or‘extremely difficult’suggest that the patient’s functionality is impaired. After treatment begins, functional status and number score can be measured to assess patient improvement.
Note: Depression should not be diagnosed or excluded solely on the basis of a PHQ-9 score. A PHQ-9 score ≥ 10 has a sensitivity of 88% and a specificity of 88% for major depression.1 Since the questionnaire relies on patient self-report, the practitioner should verify all responses. A definitive diagnosis is made taking into account how well the patient understood the questionnaire, as well as other relevant information from the patient.
PHQ-9 is adapted from PRIME MD TODAY, developed by Drs Spitzer, Williams, Kroenke and colleagues, with an educational grant from Pfizer Inc. Use of the PHQ-9 may only be made in accordance with the Terms of Use available at www.pfizer.com. Copyright © 1999 Pfizer Inc. All rights reserved. PRIME MD TODAY is a trademark of Pfizer Inc.